Interleukin-33 modulates inflammation in endometriosis

Area of Science:

• Reproductive Immunology
• Cellular and Molecular Biology

Background:

• Endometriosis is characterized by endometrial tissue outside the uterus, often involving immune dysfunction.
• Interleukin-33 (IL-33), a key regulator of inflammation, is implicated in endometriosis pathogenesis.
• Previous studies linked IL-33 levels to deep infiltrating endometriosis, but its direct role was unclear.

Purpose of the Study:

• To investigate the role of IL-33 in endometriosis pathophysiology.
• To determine IL-33's effects on endometriotic lesion development and associated inflammation.

Main Methods:

• Analysis of IL-33 levels in patient samples (lesions vs. endometrium).
• In vitro studies stimulating various cell types with IL-33.
• Utilizing a syngeneic mouse model to assess IL-33's systemic and local effects on endometriosis.

Main Results:

• Endometriotic lesions produced significantly higher IL-33 levels than healthy endometrium.
• IL-33 stimulation induced pro-inflammatory and angiogenic cytokines in vitro.
• In vivo, IL-33 treatment led to systemic inflammation, increased lesion vascularization, and proliferation.

Conclusions:

• IL-33 significantly contributes to endometriosis progression.
• IL-33 promotes inflammation, angiogenesis, and lesion proliferation, crucial for endometriosis survival and advancement.